Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Current Assets (2019 - 2025)

Korro Bio (KRRO) has disclosed Current Assets for 6 consecutive years, with $98.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Current Assets fell 35.71% year-over-year to $98.2 million, compared with a TTM value of $98.2 million through Sep 2025, down 35.71%, and an annual FY2024 reading of $131.5 million, down 23.85% over the prior year.
  • Current Assets was $98.2 million for Q3 2025 at Korro Bio, down from $102.6 million in the prior quarter.
  • Across five years, Current Assets topped out at $200.1 million in Q1 2021 and bottomed at $42.5 million in Q3 2023.
  • Average Current Assets over 5 years is $120.9 million, with a median of $121.2 million recorded in 2025.
  • The sharpest move saw Current Assets plummeted 57.92% in 2023, then skyrocketed 259.49% in 2024.
  • Year by year, Current Assets stood at $134.7 million in 2021, then plummeted by 57.64% to $57.1 million in 2022, then soared by 202.59% to $172.7 million in 2023, then dropped by 23.85% to $131.5 million in 2024, then decreased by 25.32% to $98.2 million in 2025.
  • Business Quant data shows Current Assets for KRRO at $98.2 million in Q3 2025, $102.6 million in Q2 2025, and $121.2 million in Q1 2025.